TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects

NCT03408470 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Intestinal Disorders
Bowel Diseases, Inflammatory

Interventions

DRUG: TD-1473 oral capsule
DRUG: [14C]-TD-1473 IV bolus
DRUG: [14C]-TD-1473 Oral Capsule

Sponsor

Theravance Biopharma